Halozyme Therapeutics Inc
SWB:RV7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Halozyme Therapeutics Inc
SWB:RV7
|
US |
|
ANTA Sports Products Ltd
HKEX:2020
|
CN |
|
H
|
Halma PLC
XBER:H11
|
UK |
|
H
|
Harvey Norman Holdings Ltd
SWB:HNN
|
AU |
|
W
|
Westport Fuel Systems Inc
F:WPIA
|
CA |
Wall St Price Targets
RV7 Price Targets Summary
Halozyme Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for RV7 is 73.5 EUR with a low forecast of 48.01 EUR and a high forecast of 85.57 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV7's stock price target?
Price Target
73.5
EUR
According to Wall Street analysts, the average 1-year price target for RV7 is 73.5 EUR with a low forecast of 48.01 EUR and a high forecast of 85.57 EUR.
What is the Revenue forecast for Halozyme Therapeutics Inc?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Halozyme Therapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Operating Income over the next 8 years is -5%.
What is the Net Income forecast for Halozyme Therapeutics Inc?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
